Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 3Waldenstrom Macroglobulinemia 1Stomach Neoplasms 1Recurrence 1Neoplasms, Second Primary 1Neoplasms 1NSCLC 1Lymphoma, Mantle-Cell 1Immunoglobulin Light-chain Amyloidosis 1

Interventions

Thalidomide 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Immunoglobulin Light-chain Amyloidosis × Thalidomide × Clear all
NCT04612582 2020-11-03

Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

Guangdong Provincial People's Hospital

Phase 4 Unknown
70 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡